Sign in →

Test Code LAB4049 CBC AUTO DIFFERENTIAL 

Important Note

includes CBC w/ platelet count, Automated Diff with reflex to Manual Diff. 

Specimen Type

EDTA whole Blood (Lavender Top Tube)

Specimen Volume

4 mL

Minimum Volume

0.5 mL microtainer 

Turnaround Time

STAT: 1 hour
Routine: 4 hours

Test Schedule

Daily

Sample Stability

Refrigerated: 2 days

Room Temperature: 1 day

 

 

Specimen Processing

Prefer to receive specimen within 8 hours of collection. Prefer specimen be stored and transported refrigerated unless patient is suspected of having cold agglutinins.

Method

Automated

Reference Ranges

Parameter Gender Reference Ranges
WBC, 103/µL Male 0-14 days: 8.0-15.4
15 days-4 weeks: 7.8-15.9
5 weeks-7 weeks: 8.1-15.0
8 weeks-5 months: 6.5-13.3
6 months-23 months: 6.0-13.5
24 months-35 months: 5.1-13.4
3-5 years: 4.4-12.9
6-17 years:3.8-10.4
Adult: 4.0-11.0
Female 0-14 days: 8.2-14.6
15 days-4 weeks: 8.4-14.4
5 weeks-7 weeks: 7.1-14.7
8 weeks-5 months: 6.0-13.3
6 months-23 months: 6.5-13.0
24 months-35 months: 4.9-13.2
3-5 years: 4.4-12.9
6-17 years: 3.8-10.4
Adult: 4.0-11.0
RBC, 106/µL Male 0-14 days: 4.10-5.55
15 days-4 weeks: 3.16-4.63
5 weeks-7 weeks: 3.02-4.22
8 weeks-5 months: 3.43-4.80
6 months-23 months: 4.03-5.07
24 months-35 months: 3.89-4.97
3-5 years: 4.00-5.10
6-10 years: 4.10-5.20
11-14 years: 4.20-5.30
15-17 years: 4.30-5.70
Adult: 4.30-5.70
Female 0-14 days: 4.12-5.74
15 days-4 weeks: 3.32-4.80
5 weeks-7 weeks: 2.93-3.87
8 weeks-5 months: 3.45-4.75
6 months-23 months: 3.97-5.01
24 months-35 months: 3.84-4.92
3-5 years: 4.00-5.10
6-10 years: 4.10-5.20
11-14 years: 4.10-5.10
15-17 years: 3.80-5.00
Adult: 3.80-5.20
HGB, g/dL Male 0-14 days: 13.9-19.1
15 days-4 weeks: 10.0-15.3
5 weeks-7 weeks: 8.9-12.7
8 weeks-5 months: 9.6-12.4
6 months-23 months: 10.1-12.5
24 months-35 months: 10.2-12.7
3-5 years: 11.4-14.3
6-8 years: 11.5-14.3
9-10 years: 11.8-14.7
11-14 years: 12.4-15.7
15-17 years: 13.3-16.9
Adult: 13.7-16.7
Female 0-14 days: 13.4-20.0
15 days-4 weeks: 10.8-14.6
5 weeks-7 weeks: 9.2-11.4
8 weeks-5 months: 9.9-12.4
6 months-35 months: 10.2-12.7
3-5 years: 11.4-14.3
6-8 years: 11.5-14.3
9-10 years: 11.8-14.7
11-17 years: 11.9-14.8
Adult: 11.6-15.5
HCT, % Male 0-14 days: 39.8-53.6
15 days-4 weeks: 30.5-45.0
5 weeks-7 weeks: 26.8-37.5
8 weeks-5 months: 28.6-37.2
6 months-23 months: 30.8-37.8
24 months-35 months: 31.0-37.7
3-7 years: 34-42
8-11 years: 35-43
12-15 years: 38-47
16-17 years: 40-50
Adult: 40.0-50.0
Female 0-14 days: 39.6-57.2
15 days-4 weeks: 32.0-44.5
5 weeks-7 weeks: 27.7-35.1
8 weeks-5 months: 29.5-37.1
6 months-23 months: 30.9-37.9
24 months-35 months: 31.2-37.8
3-7 years: 34-42
8-17 years: 35-43
Adult: 35.0-46.0
MCV, fL Male 0-14 days: 91.3-103.1
15 days-4 weeks: 89.4-99.7
5 weeks-7 weeks: 84.3-94.2
8 weeks-5 months: 74.1-87.5
6 months-23 months: 69.5-81.7
24 months-35 months: 71.3-84.0
3-5 years: 77.2-89.5
6-11 years: 77.8-91.1
12-14 years: 79.9-93.0
15-17 years: 82.5-98.0
Adult: 80.0-100.0
Female 0-14 days: 92.7-106.4
15 days-4 weeks: 90.1-103.0
5 weeks-7 weeks: 83.4-96.4
8 weeks-5 months: 74.8-88.3
6 months-23 months: 71.3-82.6
24 months-35 months: 72.3-85.0
3-5 years: 77.2-89.5
6-11 years: 77.8-91.1
12-14 years: 79.9-93.0
15-17 years: 82.5-98.0
Adult: 80.0-100.0
MCH, pg Both 0-2 days: 31.0-37.0
3-30 days: 28.0-37.0
1-2 months: 26.0-34.0
3-5 months: 25.0-35.0
6-24 months: 23.0-31.0
2-5 years: 24.0-30.0
6-11 years: 25.0-33.0
12-17 years: 25.0-35.0
Adult: 27.0-34.0
MCHC, g/dL Both 0-2 days: 29.0-37.0
3-13 days: 28.0-37.0
2 weeks-2 months: 29.0-37.0
3-24 months: 30.0-36.0
2-17 years: 31.0-37.0
Adult: 31.5-35.7
RDW-CV, % Male 0-14 days: 14.8-17.0
15 days-4 weeks: 14.3-16.8
5 weeks-7 weeks: 13.8-16.1
8 weeks-5 months: 12.4-15.3
6 months-23 months: 12.9-15.6
24 months-35 months: 12.5-14.9
3-5 years: 11.3-13.4
6-17 years: 11.4-13.5
Adult: 11.0-15.0
Female 0-14 days: 14.6-17.3
15 days-4 weeks: 14.4-16.2
5 weeks-7 weeks: 13.6-15.8
8 weeks-5 months: 12.2-14.3
6 months-23 months: 12.7-15.1
24 months-35 months: 12.4-14.9
3-5 years: 11.3-13.4
6-17 years: 11.4-13.5
Adult: 11.0-15.0
MPV, fL Both 9.4-12.4
PLT, 103/µL Male 0-14 days: 218-419
15 days-4 weeks: 248-586
5 weeks-7 weeks: 229-562
8 weeks-5 months: 244-529
6 months-23 months: 206-445
24 months-35 months: 202-403
3-5 years: 187-445
6-9 years: 187-400
10-13 years: 177-381
14-17 years: 139-320
Adult: 150-400
Female 0-14 days: 144-449
15 days-4 weeks: 279-571
5 weeks-7 weeks: 331-597
8 weeks-5 months: 247-580
6 months-23 months: 214-459
24 months-35 months: 189-394
3-5 years: 187-445
6-9 years: 187-400
10-13 years: 177-381
14-17 years: 158-362
Adult: 150-400
IPF, % Both 1.0-7.0 %
IPF #, 103/µL Both None established
Neut, % Both 0 days: 44.0-85.0
1-7 days: 28.0-62.0
8-13 days: 23.0-57.0
14-60 days: 18.0-52.0
3-11 months: 15.0-49.0
1-4 years: 14.0-59.0
5-12 years: 34.0-71.0
13-17 years: 40.0-74.0
Adult: 40.0-80.0
Band, % Both 0-2 days: 10.0-18.0
3-60 days: 7.0-19.0
3 months - 4 years: 5.0-12.0
5-16 years: 5.0-11.0
17 years: 0.0-8.0
Adult: 0.0-8.0
Lymph, % Both 0 days: 9.0-46.0
1-3 days: 16.0-46.0
4-7 days: 26.0-56.0
8-13 days: 33.0-63.0
14-60 days: 41.0-71.0
3 months - 4 years: 46.0-76.0
5-12 years: 23.0-57.0
13-17 years: 20.0-50.0
Adult: 15.0-45.0
Mono, % Both 0-3 days: 1.0-10.0
4-13 days: 5.0-13.0
14-60 days: 3.0-11.0
3 months - 4 years: 1.0-9.0
5-12 years: 0.0-9.0
13-17 years: 1.0-9.0
Adult: 0.0-12.0
Eos, % Both 0.0-7.0
Baso, % Both 0.0-2.0
IG, % Both 0.0-1.0
NRBC, % Both 0.0-0.2
Neut #, 103/µL Male 0-14 days: 1.60-6.06
15 days-4 weeks: 1.18-5.45
5 weeks-7 weeks: 0.83-4.23
8 weeks-5 months: 0.97-5.45
6 months-23 months: 1.19-7.21
24 months-35 months: 1.54-7.92
3-5 years: 1.60-7.80
6-16 years: 1.40-6.10
17 years: 1.80-7.20
Adult: 2.0-7.3
Female 0-14 days: 1.73-6.75
15 days-4 weeks: 1.23-4.80
5 weeks-7 weeks: 1.00-4.68
8 weeks-5 months: 1.04-7.20
6 months-23 months: 1.27-7.18
24 months-35 months: 1.60-8.29
3-5 years: 1.60-7.80
6-14 years: 1.50-6.50
15-17 years: 2.00-7.40
Adult: 2.0-7.3
Lymph #, 103/µL Male 0-14 days: 2.07-7.53
15 days-4 weeks: 2.11-8.38
5 weeks-7 weeks: 2.47-7.95
8 weeks-5 months: 2.45-8.89
6 months-23 months: 1.56-7.83
24 months-35 months: 1.13-5.52
3-5 years: 1.60-5.30
6-11 years: 1.40-3.90
12-17 years: 1.00-3.20
Adult: 1.0-3.4
Female 0-14 days: 1.75-8.00
15 days-4 weeks: 2.42-8.20
5 weeks-7 weeks: 2.29-9.14
8 weeks-5 months: 2.14-8.99
6 months-23 months: 1.52-8.09
24 months-35 months: 1.25-5.77
3-5 years: 1.60-5.30
6-11 years: 1.40-3.90
12-17 years: 1.00-3.20
Adult: 1.0-3.4
Mono #, 103/µL Male 0-14 days: 0.52-1.77
15 days-4 weeks: 0.28-1.38
5 weeks-7 weeks: 0.28-1.05
8 weeks-5 months: 0.28-1.07
6 months-23 months: 0.25-1.15
24 months-35 months: 0.19-0.94
3-5 years: 0.30-0.90
6-17 years: 0.20-0.80
Adult: 0.0-0.8
Female 0-14 days: 0.57-1.72
15 days-4 weeks: 0.42-1.21
5 weeks-7 weeks: 0.28-1.21
8 weeks-5 months: 0.24-1.17
6 months-23 months: 0.26-1.08
24 months-35 months: 0.24-0.92
3-5 years: 0.30-0.90
6-17 years: 0.20-0.80
Adult: 0.0-0.8
Eos #, 103/µL Male 0-14 days: 0.12-0.66
15 days-4 weeks: 0.08-0.80
5 weeks-7 weeks: 0.05-0.57
8 weeks-5 months: 0.03-0.61
6 months-23 months: 0.02-0.82
24 months-35 months: 0.03-0.53
3-11 years: 0.00-0.50
12-17 years: 0.10-0.20
Adult: 0.0-0.5
Female 0-14 days: 0.09-0.64
15 days-4 weeks: 0.06-0.75
5 weeks-7 weeks: 0.04-0.63
8 weeks-5 months: 0.02-0.74
6 months-23 months: 0.02-0.58
24 months-35 months: 0.03-0.46
3-11 years: 0.00-0.50
12-17 years: 0.10-0.20
Adult: 0.0-0.5
Baso #, 103/µL Male 0-14 days: 0.02-0.11
15 days-7 weeks: 0.01-0.07
8 weeks-35 months: 0.01-0.06
3-17 years: 0.00-0.10
Adult: 0.0-0.1
Female 0-14 days: 0.02-0.07
15 days-4 weeks: 0.01-0.06
5 weeks-7 weeks: 0.01-0.05
8 weeks-5 months: 0.01-0.07
6 months-35 months: 0.01-0.06
3-17 years: 0.00-0.10
Adult: 0.0-0.1
IG #, 103/µL Both 0.00-0.05
NRBC #, 103/µL Both 0.00-0.01
RET, % 0.40-1.80 IRF, %
RET #, 103/µL 21.0-86.0 RET-He, pg

 

CPT Codes

85025

Notes

  • Immature Granulocytes count (IG): The IG count (% and #) includes metamyelocytes, myelocytes and promyelocytes.  Immature granulocytes are neutrophil precursors and their presence indicates a granulocytic left shift in the blood.  Preliminary studies have indicated that the automated IG count shows promise as an early screen for infection.1  The ability to provide a more accurate and precise automated immature granulocyte count without performing a manual differential will decrease turnaround times to provide patient results sooner.

 

  • Immature Platelet Fraction (IPF):  The Immature Platelet Fraction is an index of thrombopoiesis and it may assist the physician in determining the cause and differential diagnosis of thrombocytopenia when used with patient information and the platelet count.  IPF may help the physician determine if thrombocytopenia is due to platelet destruction or decreased platelet production.4